Regulations.gov document
Freedom of Information Summary ACTOGAIN (ractopamine HCl), RUMENSIN (monensin), TYLAN…
Supporting & Related Material · FDA-2014-N-0002 · posted Jul 31, 2014
Key facts
| Document ID | FDA-2014-N-0002-0042 |
|---|---|
| Title | Freedom of Information Summary ACTOGAIN (ractopamine HCl), RUMENSIN (monensin), TYLAN (tylosin phosphate), and MGA (melengestrol acetate) Type B and C medicated feeds re New Animal Drugs; Bacitracin Methylene Disalicylate; Dinoprost Solution; Gonadorelin Hydrochloride; Progesterone Intravaginal Inserts; Salinomycin; Ractopamine; Tylosin |
| Document type | Supporting & Related Material |
| Subtype | Freedom of Information Summary |
| Agency | FDA |
| Docket | FDA-2014-N-0002 |
| Posted | Jul 31, 2014 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: